Literature DB >> 574077

Two binding sites for estradiol in rat uterine nuclei: relationship to uterotropic response.

B M Markaverich, J H Clark.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 574077     DOI: 10.1210/endo-105-6-1458

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  16 in total

1.  Type II oestrogen binding sites in human colorectal carcinoma.

Authors:  M Piantelli; R Ricci; L M Larocca; A Rinelli; A Capelli; S Rizzo; G Scambia; F O Ranelletti
Journal:  J Clin Pathol       Date:  1990-12       Impact factor: 3.411

2.  Long-term effects of estrogen on avian liver: estrogen-inducible switch in expression of nuclear, hormone-binding proteins.

Authors:  R J Haché; S P Tam; A Cochrane; M Nesheim; R G Deeley
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

3.  The binding of [3H]oestradiol-receptor complexes to calf uterine chromatin.

Authors:  T S Ruh; P Ross; D M Wood; J L Keene
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

4.  Luteolin and gefitinib regulation of EGF signaling pathway and cell cycle pathway genes in PC-3 human prostate cancer cells.

Authors:  Barry M Markaverich; Mary Vijjeswarapu; Kevin Shoulars; Mary Rodriguez
Journal:  J Steroid Biochem Mol Biol       Date:  2010-06-15       Impact factor: 4.292

5.  Heterogeneity of estrogen binding sites in breast cancer: morphologic demonstration and relationship to endocrine response.

Authors:  L P Pertschuk; K B Eisenberg; A C Carter; J G Feldman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

6.  Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.

Authors:  G Dran; I A Luthy; A A Molinolo; F Montecchia; E H Charreau; C D Pasqualini; C Lanari
Journal:  Breast Cancer Res Treat       Date:  1995-08       Impact factor: 4.872

Review 7.  1,5-diaryl-3-oxo-1,4-pentadienes: a case for antineoplastics with multiple targets.

Authors:  U Das; R K Sharma; J R Dimmock
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

8.  Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.

Authors:  Kevin Shoulars; Mary Ann Rodriguez; Trellis Thompson; Barry M Markaverich
Journal:  J Steroid Biochem Mol Biol       Date:  2009-10-27       Impact factor: 4.292

9.  65 and 47 kDa forms of estrogen receptor in human breast cancer: relation with estrogen responsiveness.

Authors:  S Jozan; A M Julia; A Carretie; N Eche; V Maisongrosse; B Fouet; B Marques; J F David
Journal:  Breast Cancer Res Treat       Date:  1991-10       Impact factor: 4.872

10.  Ultrastructural evidence for endogenous testosterone immunoreactivity in the pituitary gland of the rat.

Authors:  G Morel; M G Forest; P M Dubois
Journal:  Cell Tissue Res       Date:  1984       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.